{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:30:15Z","timestamp":1772861415132,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.repc.2022.03.006","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:00:39Z","timestamp":1673262039000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions"],"prefix":"10.1016","volume":"42","author":[{"given":"Jo\u00e3o","family":"Ferreira Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Valentim Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Ilh\u00e3o Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Pereira da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa","family":"Tim\u00f3teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delmira","family":"Pombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cla\u00fadia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Cruz Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2022.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute heart failure: definition, classification and epidemiology","volume":"14","author":"Kurmani","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.repc.2022.03.006_bib0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.549","article-title":"Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88195 patients","volume":"18","author":"Farr\u00e9","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.recesp.2019.11.020","article-title":"Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?","volume":"73","author":"Dobarro","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.repc.2017.11.010","article-title":"Heart failure in numbers: estimates for the 21st century in Portugal","volume":"37","author":"Fonseca","year":"2018","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.repc.2019.09.006","article-title":"Current costs of heart failure in Portugal and expected increases due to population aging","volume":"39","author":"Gouveia","year":"2020","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/j.repc.2022.03.006_bib0175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jchf.2016.05.001","article-title":"Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community","volume":"4","author":"Xanthakis","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardfail.2016.03.003","article-title":"Defining advanced heart failure: a systematic review of criteria used in clinical trials","volume":"22","author":"Bjork","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0185","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jchf.2020.01.014","article-title":"Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches","volume":"8","author":"Truby","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0195","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.15420\/cfr.2020.03","article-title":"Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use","volume":"6","author":"Papp","year":"2020","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.repc.2022.03.006_bib0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijcard.2017.05.081","article-title":"Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy","volume":"243","author":"P\u00f6lzl","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","article-title":"Repeated or intermittent levosimendan treatment in advanced heart failure: an updated meta-analysis","volume":"202","author":"Silvetti","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0210","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.118","article-title":"Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial","volume":"16","author":"Altenberger","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ejhf.1145","article-title":"Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial","volume":"20","author":"Com\u00edn-Colet","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0220","series-title":"Paper presented at the European Society of Cardiology \u2013 Heart Failure Association Congress","article-title":"Efficacy and security of intermittent repeated levosimendan administration in patients with advanced heart failure: a randomized, double-blind, placebo controlled multicenter trial: LAICA study","author":"Garc\u00eda-Gonz\u00e1lez","year":"2016"},{"key":"10.1016\/j.repc.2022.03.006_bib0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.recesp.2019.06.019","article-title":"Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain","volume":"73","author":"Manito Lorite","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.repc.2022.03.006_bib0230","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ejhf.1994","article-title":"Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper","volume":"22","author":"Hill","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jchf.2020.05.005","article-title":"Sacubitril\/valsartan in advanced heart failure with reduced ejection fraction: rationale and design of the LIFE Trial","volume":"8","author":"Mann","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2022.03.006_bib0245","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2022.03.006_bib0250","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1093\/eurheartj\/ehy600","article-title":"Treatments targeting inotropy","volume":"40","author":"Maack","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2022.03.006_bib0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ehf2.12366","article-title":"Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period","volume":"6","author":"P\u00f6lzl","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.12047","article-title":"Levosimendan improves exercise performance in patients with advanced chronic heart failure","volume":"2","author":"Mushtaq","year":"2015","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.320","article-title":"Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?","volume":"17","author":"Stienen","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2022.03.006_bib0270","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cardfail.2007.04.004","article-title":"A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure","volume":"13","author":"Mavrogeni","year":"2007","journal-title":"J Card Fail"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:12:16Z","timestamp":1760109136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255123000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0870255123000483"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2022.03.006","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}